TipRanks
Go Ultimate55% OFF

Lytix Biopharma AS (6BG) Balance Sheet

Lytix Biopharma AS Balance Sheet

Lytix Biopharma AS's total assets for Q2 2026 were $100.33M, a decrease of 22.10% from the previous quarter. DE:6BG total liabilities were $13.71M for the fiscal quarter, a 4.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 81.52M$ 146.53M$ 63.87M$ 153.27M$ 202.96M
$ 19.77M$ 38.64M$ 12.55M$ 18.23M$ 13.34M
$ 61.75M$ 107.89M$ 51.32M$ 135.03M$ 189.62M

Currency in NOK

Lytix Biopharma AS Debt to Assets

080M160M240M0 %15 %30 %45 %LiabilitiesDebt to Assets20182019202020212022202320242025AssetsLiabilitiesDebt to Assets